212 related articles for article (PubMed ID: 19661114)
1. Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy.
Kronborg MB; Albertsen AE; Nielsen JC; Mortensen PT
Europace; 2009 Sep; 11(9):1177-82. PubMed ID: 19661114
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of cardiac resynchronization therapy in very old patients: the Insync/Insync ICD Italian Registry.
Achilli A; Turreni F; Gasparini M; Lunati M; Sassara M; Santini M; Landolina M; Padeletti L; Puglisi A; Bocchiardo M; Orazi S; Perego GB; Valsecchi S; Denaro A
Europace; 2007 Sep; 9(9):732-8. PubMed ID: 17636304
[TBL] [Abstract][Full Text] [Related]
4. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
5. Six-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapy.
Castel MA; Méndez F; Tamborero D; Mont L; Magnani S; Tolosana JM; Berruezo A; Godoy M; Sitges M; Vidal B; Roig E; Brugada J
Europace; 2009 Mar; 11(3):338-42. PubMed ID: 19136491
[TBL] [Abstract][Full Text] [Related]
6. Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling.
Lilli A; Ricciardi G; Porciani MC; Perini AP; Pieragnoli P; Musilli N; Colella A; Del Pace S; Michelucci A; Turreni F; Sassara M; Achilli A; Barold SS; Padeletti L
Pacing Clin Electrophysiol; 2007 Nov; 30(11):1349-55. PubMed ID: 17976098
[TBL] [Abstract][Full Text] [Related]
7. Long-term performance of the attain model 4193 left ventricular lead.
Johnson WB; Abraham WT; Young JB; Wheelan K; Smith AL; Chang Y; Brinkman P;
Pacing Clin Electrophysiol; 2009 Sep; 32(9):1111-6. PubMed ID: 19719485
[TBL] [Abstract][Full Text] [Related]
8. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic patterns and long-term clinical outcome in cardiac resynchronization therapy.
Kronborg MB; Nielsen JC; Mortensen PT
Europace; 2010 Feb; 12(2):216-22. PubMed ID: 19915182
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of cardiac resynchronization therapy in octogenarians: a comparative study with a younger population.
Foley PW; Chalil S; Khadjooi K; Smith RE; Frenneaux MP; Leyva F
Europace; 2008 Nov; 10(11):1302-7. PubMed ID: 18827063
[TBL] [Abstract][Full Text] [Related]
11. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
Bulava A; Lukl J
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
[TBL] [Abstract][Full Text] [Related]
12. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
[TBL] [Abstract][Full Text] [Related]
13. Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experience.
Cha YM; Rea RF; Wang M; Shen WK; Asirvatham SJ; Friedman PA; Munger TM; Espinosa RE; Hodge DO; Hayes DL; Redfield MM
J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1015-9. PubMed ID: 17711439
[TBL] [Abstract][Full Text] [Related]
14. Cardiac resynchronization therapy in patients with mildly impaired left ventricular function.
Foley PW; Stegemann B; Smith RE; Sanderson JE; Leyva F
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S186-9. PubMed ID: 19250090
[TBL] [Abstract][Full Text] [Related]
15. Influence of left ventricular lead location on outcomes in the COMPANION study.
Saxon LA; Olshansky B; Volosin K; Steinberg JS; Lee BK; Tomassoni G; Guarnieri T; Rao A; Yong P; Galle E; Leigh J; Ecklund F; Bristow MR
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):764-8. PubMed ID: 19298563
[TBL] [Abstract][Full Text] [Related]
16. Long-term stability of endocardial left ventricular pacing leads placed via the coronary sinus.
Lin G; Anavekar NS; Webster TL; Rea RF; Hayes DL; Brady PA
Pacing Clin Electrophysiol; 2009 Sep; 32(9):1117-22. PubMed ID: 19719486
[TBL] [Abstract][Full Text] [Related]
17. Limited response to cardiac resynchronization therapy in patients with concomitant right ventricular dysfunction.
Tabereaux PB; Doppalapudi H; Kay GN; McElderry HT; Plumb VJ; Epstein AE
J Cardiovasc Electrophysiol; 2010 Apr; 21(4):431-5. PubMed ID: 19845815
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
[TBL] [Abstract][Full Text] [Related]
19. Rate-responsive pacing in patients with heart failure: long-term results of a randomized study.
Nägele H; Rödiger W; Castel MA
Europace; 2008 Oct; 10(10):1182-8. PubMed ID: 18723519
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
